Cargando…

Clinical Outcomes of Patients With Primary Membranous Nephropathy and Subnephrotic Proteinuria

Objectives: To update the information about the prognosis of patients with primary membranous nephropathy (MN) and subnephrotic proteinuria and identify the relevant predictors. Methods: In total, 474 cases of biopsy-proven primary MN with at least 18 months of follow-up were reviewed to determine t...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Peng, Zha, Yang, Liu, Jing, Wang, Hanmin, He, Lijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674415/ https://www.ncbi.nlm.nih.gov/pubmed/34926493 http://dx.doi.org/10.3389/fmed.2021.737700

Ejemplares similares

Microhematuria Enhances the Risks of Relapse and Renal Progression in Primary Membranous Nephropathy
por: He, Peng, et al.
Publicado: (2021)

The diagnostic value of native kidney biopsy in low grade, subnephrotic, and nephrotic range proteinuria: A retrospective cohort study
por: de Fallois, Jonathan, et al.
Publicado: (2022)

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
por: Dong, Yaping, et al.
Publicado: (2023)

The Association Between Serum Complement 4 and Kidney Disease Progression in Idiopathic Membranous Nephropathy: A Multicenter Retrospective Cohort Study
por: Liu, Jing, et al.
Publicado: (2022)

The Active Compounds and Therapeutic Target of Tripterygium wilfordii Hook. f. in Attenuating Proteinuria in Diabetic Nephropathy: A Review
por: Liu, Peng, et al.
Publicado: (2021)

Hematuria was a high risk for renal progression and ESRD in immunoglobulin a nephropathy: a systematic review and meta-analysis
por: He, Peng, et al.
Publicado: (2021)

The Effect of Hydroxychloroquine on Residual Proteinuria in Patients With Immunoglobulin A Nephropathy: A Retrospective Study Based on Propensity Score Matching
por: Liu, Mijia, et al.
Publicado: (2022)

Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
por: Zhao, Jing-Li, et al.
Publicado: (2021)

Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2019)

Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort
por: Gao, Shuang, et al.
Publicado: (2021)

Glomerulosclerosis is a prognostic risk factor in patients with membranous nephropathy and non-nephrotic proteinuria
por: Sun, Jing, et al.
Publicado: (2023)

Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy
por: Barrett, Christine, et al.
Publicado: (2020)

The Significance of Crescents on the Clinical Features and Outcomes of Primary Immunoglobin A Nephropathy
por: Du, Yongjing, et al.
Publicado: (2022)

Immune-Monitoring Disease Activity in Primary Membranous Nephropathy
por: Cravedi, Paolo, et al.
Publicado: (2019)

Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria
por: Iwasaki, Chihiro, et al.
Publicado: (2016)

Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission
por: Inagaki, Koji, et al.
Publicado: (2017)

Associations between liver function parameters and poor clinical outcomes in peritoneal dialysis patients
por: Song, Xiyu, et al.
Publicado: (2022)

The role of sirolimus in proteinuria in diabetic nephropathy rats
por: Wang, JinJun, et al.
Publicado: (2017)

Mechanisms of Proteinuria in HIV
por: Hall, Gentzon, et al.
Publicado: (2021)

Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis
por: Zheng, Shirong, et al.
Publicado: (2016)

The Calcineurin Inhibitor Tacrolimus Reduces Proteinuria in Membranous Nephropathy Accompanied by a Decrease in Angiopoietin-Like-4
por: Peng, Lei, et al.
Publicado: (2014)

Rapamycin Ameliorates Proteinuria and Restores Nephrin and Podocin Expression in Experimental Membranous Nephropathy
por: Stratakis, Stavros, et al.
Publicado: (2013)

Tacrolimus decreases proteinuria in patients with refractory IgA nephropathy
por: Hu, Tingyang, et al.
Publicado: (2018)

Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study
por: Kumar, Sanjeev, et al.
Publicado: (2012)

Monogenic Causes of Proteinuria in Children
por: Cil, Onur, et al.
Publicado: (2018)

Editorial: Molecular Mechanisms of Proteinuria
por: Merscher, Sandra
Publicado: (2018)

Clinical Efficacy of Routinely Administered Belimumab on Proteinuria and Neuropsychiatric Lupus
por: Plüß, Marlene, et al.
Publicado: (2020)

Urinary Protein-to-Creatinine Ratio: An Indicator of Adverse Clinical Outcomes in Preeclampsia With Proteinuria
por: Chadha, Arzoo, et al.
Publicado: (2022)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy
por: Hartono, Choli, et al.
Publicado: (2018)

Clinical covariates influencing clinical outcomes in primary membranous nephropathy
por: Westermann, Lukas, et al.
Publicado: (2023)

Case Report: A Pathogenic Missense Variant of WT1 Cosegregates With Proteinuria in a Six-Generation Chinese Family With IgA Nephropathy
por: Li, Qianqian, et al.
Publicado: (2022)

Spot urine protein/creatinine ratio as a reliable estimate of 24-hour proteinuria in patients with immunoglobulin A nephropathy, but not membranous nephropathy
por: Kobayashi, Seiji, et al.
Publicado: (2019)

Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function
por: Tan, Min, et al.
Publicado: (2019)

Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014)

Hydroxychloroquine Reduces Proteinuria in Indian Patients With IgA Nephropathy
por: Bagchi, Soumita, et al.
Publicado: (2022)

Retrospective analysis of Tripterygium wilfordii polyglycoside combined with angiotensin receptor blockers for the treatment of primary membranous nephropathy with sub-nephrotic proteinuria
por: Guo, Yuanyuan, et al.
Publicado: (2021)

Treatment of Idiopathic Membranous Nephropathy for Moderate or Severe Proteinuria: A Systematic Review and Network Meta-Analysis
por: Chen, Miaomiao, et al.
Publicado: (2022)

Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy
por: Luo, Wentian, et al.
Publicado: (2018)

Clinical Efficacy of Dapagliflozin in the Treatment of Patients with Diabetic Nephropathy and Its Effect on Proteinuria Level
por: Jin, Ze-Jun, et al.
Publicado: (2023)

Correction to: Clinical covariates influencing clinical outcomes in primary membranous nephropathy
por: Westermann, Lukas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ujhr40f22f3t0tb2nkk7dkah27